MgAl monolayer hydrotalcite increases the hypoglycemic effect of berberine by enhancing its oral bioavailability

Berberine (BBR) is a potential novel agent to treat diabetes, but its oral bioavailability is restricted by the poor solubility, which greatly limits its clinical application. Here, a new drug delivery system of BBR-MgAl monolayer hydrotalcite (BBR/MLDH) was prepared to increase the solubility and b...

Full description

Bibliographic Details
Main Authors: Aiting Wang, Wei Yang, Xinyu Yang, Xuan Mei, Tingting Hu, Ruizheng Liang, Dali Meng, Dan Yan
Format: Article
Language:English
Published: Elsevier 2020-07-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332220303322